Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 14/20 | 0.45 |
| ▸ | LDHB | P07195 | 12/20 | 0.45 |
| ▸ | EGFR | P00533 | 5/20 | 0.42 |
| ▸ | KDR | P35968 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22862715 | 1.00 | LDHA (0.45) | LDHALDHBEGFRKDR | |
| SCHEMBL29490260 | 0.89 | RAB9A (0.38) | LDHALDHBEGFRKDR | |
| SCHEMBL22862570 | 0.89 | RAB9A (0.38) | LDHALDHBEGFRKDR | |
| SCHEMBL22862684 | 0.89 | EGFR (0.49) | LDHALDHBEGFRKDR | |
| SCHEMBL29490218 | 0.89 | EGFR (0.49) | LDHALDHBEGFRKDR | |
| SCHEMBL22862694 | 0.86 | EGFR (0.39) | EGFRKDR | |
| SCHEMBL29490224 | 0.84 | EGFR (0.44) | EGFRKDR | |
| SCHEMBL22862653 | 0.84 | EGFR (0.44) | EGFRKDR | |
| SCHEMBL22862575 | 0.84 | EGFR (0.37) | EGFRKDR | |
| SCHEMBL29490242 | 0.84 | EGFR (0.37) | EGFRKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132147-A1 | BAX INHIBITORS AND USES THEREOF | CASE WESTERN RESERVE UNIV (US) | 2026-05-14 | — | — | US | disclosed |
| EP-3976009-A2 | BAX INHIBITORS AND USES THEREOF | Case Western Reserve University (US) | 2022-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132147-A1 | BAX INHIBITORS AND USES THEREOF | BAX, BCL2, BAK1 | LDHA 1315/4885LDHB 618/4885EGFR 785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.